Other tumor types included papillary RCC (n = 10), angiomyolipoma (n = 6), oncocytoma (n = 6), chromophobe RCC (n = 3), unclassified RCC (n = 3), hybrid oncocytic tumors (n = 2), and TFEB-amplified RCC (n = 1) (eFigure in the Supplement). This evidence concerns the gene TFEB and angiomyolipoma.